Both the studies in European patients showed HLA-DRB1*15 to be associated with viral clearance [33, 35] and could, therefore, in part explain the lower risk for MS in Swedish patients with HCV. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.